A proposal for an international retinoblastoma staging system

Pediatric Blood and Cancer

Volumn 47, Issue 6, 2006, Pages 801-805

  Chantada, Guillermo ^a   Doz, François ^b   Antoneli, Celia B G ^c   Grundy, Richard ^d   Stannard, F F Clare ^e   Dunkel, Ira J ^f   Grabowski, Eric ^g   Leal Leal, Carlos ^h   Rodríguez Galindo, Carlos ⁱ   Schvartzman, Enrique ^a   Popovic, Maja Beck ^j   Kremens, Bernhard ^k   Meadows, Anna T ^l   Zucker, Jean Michel ^b  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^b INSTITUT CURIE   (France)

^c A C CAMARGO CANCER CENTER   (Brazil)

^d BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

ⁱ ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^j LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^k UNIVERSITY OF DUISBURG ESSEN   (Germany)

^l CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

more..

Author keywords

Classification; Extra ocular; Metastasis; Retinoblastoma; Staging

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CENTRAL NERVOUS SYSTEM TUMOR; CERVICAL LYMPH NODE; CHILDHOOD CANCER; CONSENSUS; CONSERVATIVE TREATMENT; DISEASE SEVERITY; EARLY CANCER; ENUCLEATION; HEMATOLOGIC DISEASE; HISTOPATHOLOGY; HUMAN; INTERNATIONAL COOPERATION; LYMPH NODE METASTASIS; MEDICAL EXPERT; MENINGEAL METASTASIS; METASTASIS; MINIMAL RESIDUAL DISEASE; MULTIPLE CANCER; ORBIT CANCER; PRIORITY JOURNAL; RETINOBLASTOMA;

HUMANS; NEOPLASM STAGING; RETINAL NEOPLASMS; RETINOBLASTOMA;

EID: 33749181569     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20606     Document Type: Article

References (25)

1. Shields C, Shields J, Baez K, et al. Choroidal invasion of retinoblastoma: Metastatic potential and clinical risk factors. Br J Ophthalmol 1993;77:544-548.
2. Chantada G, Fandino A, Davila MT, et al. Results of a prospective study for the treatment of retinoblastoma. Cancer 2004;100:834-842.
3. Murphree AL. Intraocular retinoblastoma: The case for a new group classification. Ophthalmol Clin North Am 2005;18:41-53.
4. Ellsworth RM. The practical management of retinoblastoma. Trans Am Ophthalmol Soc 1969;67:462-534.
5. Shields CL, Mashayekhi A, Demirci H, et al. Practical approach to management of retinoblastoma. Arch Ophthalmol 2004;122:729-735.
6. Erwenne CM, Franco EL. Age and lateness of referral as determinants of extraocular retinoblastoma. Ophthalmic Paediatr Genet 1989;80:171-174.
7. Pratt CB, Fontanesi J, Chenaille P, et al. Chemotherapy for extraocular retinoblastoma. Pediatr Hematol Oncol 1994;11:301-309.
8. Namouni F, Doz F, Tanguy ML, et al. High dose chemotherapy with carboplatin, etoposide and cyclophosphamide followed by hematopoietic stem cell rescue in patients with high risk retinoblastoma: A SFOP and SFGM study. Eur J Cancer 1997;33:2368-2375.
9. Dunkel U, Aledo A, Kernan NA, et al. Successful treatment of metastatic retinoblastoma. Cancer 2000;89:2117-2121.
10. Bellaton E, Bertozzi A, Behar C, et al. Neoadjuvant chemotherapy for extensive unilateral retinoblastoma. Br J Ophthalmol 2003;87:327-329.
11. Stannard C, Sealy R, Hering E, et al. Post enucleation orbits in retinoblastoma: Treatment with 1251 brachytherapy. Int J Radiat Oncol Biol Phys 2002;54:1446-1454.
12. Grabowski E, Abramson D. Intraocular and extraocular retinoblastoma. Hematol Oncol Clin North Am 1987;1:721-735.
13. Abramson DH, Dunkel IJ, McCormick B, Neoplasms of the eye. Cancer Medicine. 5th edition. 2000. pp 1083-1096.
14. Howarth C, Meyer D, Hustu HO, et al. Stage-related combined modality treatment of retinoblastoma. Results of a prospective study. Cancer 1980;45:851-858.
15. Pratt CB, Fontanesi I, Lu X, et al. Proposal for a new staging scheme for intraocular and extraocular retinoblastoma based on an analysis of 103 globes. Oncologist 1997;2:1-5.
16. Wolff JA, Boesel C, Ellsworth R, et al. Extraocular retinoblastoma. Children Cancer Study Group Protocol CCSG 962. New York: Children Cancer Group; 1978.
17. American Joint Committee on Cancer Retinoblastoma. Manual for staging of cancer. 6th edition. 2002.
18. Khelfaoui F, Validre P, Auperin A, et al. Histopathologic risk factors in retinoblastoma. A retrospective study of 172 patients treated in a single institution. Cancer 1996;77:1206-1213.
19. Uusitalo M, Van Quill K, Scott I, et al. Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination. Arch Ophthalmol 2001;119:41-48.
20. Honavar G, Singh A, Shields C, et al. Post enucleation adjuvant therapy in high risk retinoblastoma. Arch Ophthalmol 2002;120:923-931.
21. Abramson DH, Schefler AC, Almeida D, et al. Optic nerve tissue shrinkage during pathologic processing after enucleation for retinoblastoma. Arch Ophthalmol 2003;121:73-75.
22. Rubin CM, Robison LL, Cameron JD, et al. Intraocular retinoblastoma group V: An analysis of prognostic factors. J Clin Oncol 1985;3:680-685.
23. Doz F, Khelfaoui F, Mosseri V, et al. The role of chemotherapy in orbital involvement of retinoblastoma. The experience of a single institution with 33 patients. Cancer 1994;74:722-732.
24. Pratt C, Meyer D, Chenaille P, et al. The use of bone marrow aspirations and lumbar punctures at the time of diagnosis of retinoblastoma. J Clin Oncol 1989;7:140-143.
25. Stannard CE, Sealy R, Sevel D, et al. Treatment of malignant meningitis in retinoblastoma. Br J Ophthalmol 1979;59:362-365.